Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Medinol receives CE Mark for new cobalt chromium coronary stent

Medinol : 13 May, 2008  (New Product)
Medinol has received a CE Mark for its Presillion CoCr Coronary Stent, enabling physicians to treat coronary artery lesions with a technologically innovative flexible closed cell design stent.
Presillion preserves the superb scaffolding the unprecedented balance of flexibility and conformability identified with the NIRflex flexible closed cell design.

The geometry of the Presillion complies with the long term needs of patients for both safety and efficacy in addition to ease of delivery for the physicians. The alternating rings provide simultaneously optimal flexibility and enhanced scaffolding.

Dr Kobi Richter, chairman of the board and chief technology officer of Medinol said, 'Cobalt Chromium enables us to reduce the strut thickness and overall cell size by up to 25 percent compared to stainless steel while retaining superior scaffolding through the unique flexible closed cell design; this material also maintains a much higher fatigue resistance and radiopacity than the common stainless steel stents.'

'Medinol is proud to introduce a new family of Stent systems to the market, the first of which is the Presillion. By utilising its expertise and IP Medinol is proving itself once again as a leading developer, designer and manufacturer of stents and Stent systems,' said Dr Judith Richter, chief executive officer for Medinol.

Medinol partnered with Cordis, a Johnson and Johnson company, last year, and will be distributing the Presillion globally. 'We are happy that we are able to enrich Cordis's Cath Lab Cubed offer to market,' said Dr Richter.

Recent research recognised the value of Bare Metal Stents and the growing versatility of treatments of complex coronary artery disease. The introduction of the Presillion enhances the physicians' ability to choose the most suitable Stent for each patient and the long term benefits provided for each individual vessel and lesion.

The Presillion comes in diameters ranging from 2.5 to 4.0mm. and in lengths ranging from 8 to 32mm. The Presillion Stent system and can be used to treat various lesion types: de novo, restenotic lesions, total occlusions, bifurcations, and acute myocardial infarction.

Medinol continues setting new standards in the stenting industry through design innovation and advance technology manufacturing methods. Medinol is constantly enhancing its technology and producing stenting solutions for: coronary and vascular systems, bifurcation stenting and biliary stenting. Medinol is currently developing advanced technology stents and additional therapeutic solutions for the treatment of vascular disease that will be introduced to the market in the near future.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo